In Rush for Regulatory Approval of COVID Vaccines, Do We Need More Data?
After rollout under emergency authorisation, manufacturers of COVID vaccines now have their sights on regulatory approval — but should we rush approval based on only six months’ worth of data from unblinded trials? In April 2021, Pfizer and Moderna announced
Read More